Carmel biotech firm lands $8M .pdf
Original filename: Carmel biotech firm lands $8M.pdf
Author: Strandlund, Lauren
This PDF 1.5 document has been generated by Microsoft® Word 2013, and has been sent on pdf-archive.com on 11/05/2017 at 16:36, from IP address 96.82.x.x.
The current document download page has been viewed 84 times.
File size: 204 KB (1 page).
Privacy: public file
Download original PDF file
Carmel biotech firm lands $8M in venture
capital, grant funds
May 5, 2017
Fast BioMedical Inc., a Carmel-based biotech firm developing technologies to measure blood
volumes and kidney function, has secured $8 million in venture capital and grant funds to help it
advance clinical trials.
The company announced the financing on Wednesday, and said some of the money also would
be used to hire additional workers and advance its patent portfolio. The company did not say
how many workers it planned to hire. Officials could not be reached immediately for comment.
“This financing is an important and validating step to continue our progress," CEO Joe Muldoon
said in a statement. “We have already begun adding talent to the team, and are excited about
their ability to immediately add value.”
Of the money raised, $5 million is coming in the form of early-stage, Series A2 venture capital
from one investor, F&M Investment Office LLC of Indianapolis. The other $3 million is coming
from a grant from the National Institute of Diabetes and Digestive and Kidney Diseases at the
National Institutes of Health.
Fast BioMedical, founded in 2006, is developing technologies to help patients with congestive
heart failure, major surgery, sepsis and kidney disease. The company’s technology is designed to
measure the volume status of a patient’s blood in 15 minutes.
Earlier investors include Elevate Ventures, Indiana 21st Century Fund, Rose-Hulman Ventures,
BioCrossroads, Indiana University Medical Group, Purdue Foundry Fund, Ellipsis Ventures and
Indiana companies grabbed $27.3 million in venture capital in the first quarter over 11 deals—
for an average of about $2.5 million per deal. Indiana firms averaged about that amount in 2016,
while many surrounding Midwestern states had deal averages above $5 million.